SJT: Who Signs the Prescription Owns the Risk (Free MSRA Revision)

Prescribing is one of the highest-risk decisions a doctor makes. This episode breaks down the GMC’s prescribing guidance into a clear, exam-ready framework covering accountability, high-risk medicines, remote prescribing rules, consent, information-sharing, controlled drugs, off-label use and the real-world safety traps that appear repeatedly in MSRA SJT questions. You’ll also learn the exact moments where the safest option is to pause, verify or refuse a prescription entirely. Chapters: - Why prescribing is legally high-stakes - Accountability: the signatory owns the risk - Team and system influence vs individual responsibility - Adequate knowledge and clinical justification - Remote prescribing: when it is and isn’t safe - Mandatory in-person rule: cosmetic injectables - When uncertainty mandates seeing the patient - Prescribing for yourself or relatives - Controlled drugs and the hard prohibitions - Emergency exceptions and documentation duties - Preventing doctor-shopping and closing the loop - Off-label and unlicensed medicines: added responsibilities - Patient dialogue: risks, side effects and monitoring - Refusal to share information with GP: when to refuse treatment - Shared-care arrangements: clarity, suitability, best interests - Repeat prescriptions and post-discharge safety checks - Recognising adherence red flags - Yellow Card Scheme requirements - Black triangle medicines and reporting duties - Prescribing in competitive sports: strict prohibition - Final safety framework for the MSRA Chapters_timestamps: - 00:00 Accountability at the moment of signature - 00:20 Prescribing as a legal risk assessment - 00:58 GMC prescribing framework - 01:22 Adequate clinical knowledge - 01:39 Individual accountability vs team advice - 02:00 Signatory responsibility - 02:20 Required safety resources (BNF, NICE, MHRA) - 02:48 Remote vs in-person prescribing - 03:05 Mandatory physical exam for injectables - 03:39 When uncertainty mandates face-to-face review - 04:11 Avoid prescribing for self/relatives - 04:26 Controlled drugs: near-total prohibition - 05:03 Emergency exceptions - 05:30 Preventing unsafe repeat prescribing - 06:00 Off-label prescribing responsibilities - 06:26 Informing patients and consent rules - 07:01 Refusal to share with GP and safety conflict - 07:40 Shared-care duties - 08:20 Repeat prescription safety checks - 09:38 Yellow Card reporting and black triangle medicines - 10:24 Prescribing and competitive sport ethics - 10:50 Three key takeaways Key_takeaways: - The doctor who signs the prescription always carries full professional accountability. - High-risk areas (injectables, controlled drugs, off-label use) require strict safeguards and clear justification. - When patient refusal to share information creates risk, the doctor must prioritise safety and may need to refuse treatment. Links: - passthemsra.com – Complete MSRA revision, notes, mocks, flashcards - freemsra.com – Free podcasts, threads and rapid-learning guides - msra.io – Smart MSRA Qbank with analytics #MSRA #SJT #PrescribingSafety #GMCGuidance #GoodMedicalPractice #ControlledDrugs #OffLabelPrescribing #PatientSafety #UKDoctors #GPTraining #MedicalRevision #MedEd #passthemsra #freemsra #msraio